Integrated Medical Weight Loss
1050 Main Street · East Greenwich, RI 02818
4.5(4 Google reviews · 2 in past year)
Restore Hyper Wellness · 1000 Division Street · East Greenwich, RI 02818
4.9· 56 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
East Greenwich, Rhode Island, is home to a Restore Hyper Wellness studio, a wellness business whose website cites 210+ locations nationwide. The company site lists IV drips, cryotherapy and red light therapy among its therapies and mentions a research team, details shared across its studios including East Greenwich. Both IV services and weight-loss care appear in the East Greenwich location's listing. A telehealth option is listed for the East Greenwich studio too. The East Greenwich studio's 4.9-star Google rating rests on 56 reviews beginning in 2024, 12 of them within the past year; the staff and the team's knowledge are the most common subjects. Clinicians named on the brand's site include Diane Counce, MD, and Angela Willis, MD; who is involved at East Greenwich is worth confirming directly.
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Yes |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-28. Read the reviews themselves on the practice's Google listing.
Rated ★4.9 across 56 Google reviews. Of the 53 reviews we analyzed, 52 (98%) are positive (4–5★) and 1 (2%) are negative (1–2★).
Very few complaints — only 1 negative review, with no recurring theme.
Nadine D.★★★★★2026-09-28Very welcoming and caring, knowledgeable and very clean place
Todd G.★★★★★2026-09-13I walked in the day before my Spartan event feeling beat up—general muscle inflammation, achy knees, and that familiar soreness that comes with training hard at 53. Based on their recommendations, I tried cryotherapy, followed it with red light therapy, and finished the session with compression therapy on my legs. Honestly, I was surprised by how much better I felt when everything was done. My body felt looser, my knees felt better, and I walked out feeling far more prepared for race day. Anytime you walk out feeling better than when you walked in, that’s a win! I’m already looking forward to my next session to see how much better my body can feel—and perform.
Deidra T.★★★★★2026-01-05Great place to come and have some down time for you. Staff are very helpful and friendly.
Terry L.★★★★★2025-12-02Sam at Restore East Greenwich is wonderful/ professional - always a pleasure to see. Love cryo and red light therapy here!
Yvette H.★★★★★2025-11-15The staff and nurses are all incredible and helpful and Hayley‘s facials are amazing. all the wellness services they offer are so important for our well-being and health. Grateful.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
1050 Main Street · East Greenwich, RI 02818
4.5(4 Google reviews · 2 in past year)
63 Cedar Avenue · East Greenwich, RI 02818
5.0(158 Google reviews · 9 in past year)
175 Main Street · East Greenwich, RI 02818
4.8(153 Google reviews · 26 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs